1. What industry and in particular personnel expertise did you draw on to navigate often uncertain political, social and economic conditions that resulted in the outcome announced yesterday? You're going to have to help me here, what announcement are you talking about.
2. If question 1 formed part of an individual performance review balanced scorecard rating, what score would you give the individual personnel? We dont make broad or public comment on individual's performance assessment.
3. What risk mitigation strategies did you employ to maintain agility to navigate often uncertain political, social and economic conditions? That question is a bit too broad to answer in a forum like this. Do you have some specifics?
4. Who designed and was accountable for the risk mitigation strategy? Again, its a bigger question but happy to discuss what I think might answer this. But first I'd like to get your thoughts on answers to date.
5. What is the purpose of maintaining the IABACA finalist banner on the website from 2018? All shareholders know ECT was a finalist however the winner of the award bagged it for a plug and play app for their mobile devices. The award is not a comparison of technologies nor do they advose us in how they make this decision.
We will remove the banner, as I agree, its dated.
- Forums
- ASX - By Stock
- ECT
- ECT Q&A thread 23/7
ECT Q&A thread 23/7, page-19
-
- There are more pages in this discussion • 270 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.001(16.7%) |
Mkt cap ! $11.10M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $419 | 127.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
53 | 19761726 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 12532403 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
53 | 19761726 | 0.003 |
21 | 14265353 | 0.002 |
11 | 17800024 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 12532403 | 23 |
0.005 | 4374813 | 26 |
0.006 | 5239567 | 10 |
0.007 | 1118334 | 6 |
0.008 | 332213 | 4 |
Last trade - 15.43pm 15/07/2024 (20 minute delay) ? |
Featured News
ECT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online